Mary Brawner
GlaxoSmithKline (United Kingdom)(GB)New Frontier(US)
Publications by Year
Research Areas
RNA and protein synthesis mechanisms, Bacterial Genetics and Biotechnology, Enzyme Structure and Function, Chemokine receptors and signaling, Immune Cell Function and Interaction
Most-Cited Works
- → xylE functions as an efficient reporter gene in Streptomyces spp.: use for the study of galP1, a catabolite-controlled promoter(1989)213 cited
- → Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils(1997)162 cited
- → Nonpeptide Tachykinin Receptor Antagonists: I. Pharmacological and Pharmacokinetic Characterization of SB 223412, a Novel, Potent and Selective Neurokinin-3 Receptor Antagonist(1997)107 cited
- → Stroke Genomics: Approaches to Identify, Validate, and Understand Ischemic Stroke Gene Expression(2001)89 cited
- → Two promoters, one inducible and one constitutive, control transcription of the Streptomyces lividans galactose operon.(1987)72 cited
- → Gene organization and structure of the Streptomyces lividans gal operon(1988)69 cited
- → Native Complex Formation between Apolipoprotein E Isoforms and the Alzheimer's Disease Peptide Aβ(1996)55 cited
- → Interferon action: Transcriptional control of a gene specifying a 56,000-Da protein in ehrlich ascites tumor cells(1985)42 cited
- → Two transcribing activities are involved in expression of the Streptomyces galactose operon(1989)40 cited
- → Soluble Forms of the Human T Cell Receptor CD4 are Efficiently Expressed by Streptomyces lividans(1993)38 cited